Search

Search Results

• Achieving the cure of follicular lymphoma: is it time to finalize treatment strategies to reach this goal in a subset of patients?

  Mauro Passucci, Giovanni Assanto, Alessandro Pulsoni

  e2023018

  2023-02-28

  https://doi.org/10.4084/MJHID.2023.018

  1245

  PDF: 920

  HTML: 365

• INFLUENZA AND PNEUMOCOCCAL VACCINATION IN HEMATOLOGICAL MALIGNANCIES: A SYSTEMATIC REVIEW OF EFFICACY, EFFECTIVENESS AND SAFETY

  Giuseppe La Torre

  e2016044

  2016-09-01

  https://doi.org/10.4084/mjhid.2016.044

  4728

  PDF: 1497

  HTML: 3147

• ?-THALASSEMIA DISTRIBUTION IN THE OLD WORLD: A HISTORICAL STANDPOINT OF AN ANCIENT DISEASE

  Vincenzo De Sanctis

  e2017018

  2017-02-20

  https://doi.org/10.4084/mjhid.2017.018

  11180

  PDF: 4377

  HTML: 4371

• ASSOCIATION OF MYCOBACTERIUM TUBERCULOSIS LINEAGES WITH IFN-? AND TNF-? GENE POLYMORPHISMS AMONG PULMONARY TUBERCULOSIS PATIENT

  Mohammad Varahram, Parissa Farnia, Mohammad Javad Nasiri, Mona Afraei Karahrudi, Mehdi Kazampour, Ali Akbar Velayati

  e2014015

  2014-02-16

  https://doi.org/10.4084/mjhid.2014.015

  1611

  PDF: 940

  HTML: 2221

• EARLY PREDICTORS OF RENAL DYSFUNCTION IN ?-THALASSEMIA MAJOR AND INTERMEDIA PATIENTS

  Azza A.G. Tantawy, Nagham El Bablawy, Amira A. M Adly, Fatma S E Ebeid

  e2014057

  2004-09-01

  https://doi.org/10.4084/mjhid.2014.057

  1978

  PDF: 954

  HTML: 3809

• ROLE OF COMORBIDITIES IN OPTIMIZING DECISION-MAKING FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

  Mohamed L. Sorror, Rainer F. Storb

  e2010015

  2010-06-08

  https://doi.org/10.4084/mjhid.2010.015

  1015

  PDF: 642

  HTML: 2232

• A MULTICENTER ICET-A SURVEY ON ADHERENCE TO ANNUAL ORAL GLUCOSE TOLERANCE TEST (OGTT) SCREENING IN TRANSFUSION-DEPENDENT THALASSEMIA (TDT) PATIENTS - THE EXPERT CLINICIANS’ OPINION ON FACTORS INFLUENCING THE ADHERENCE AND ON ALTERNATIVE STRATEGIES FOR ADHERENCE OPTIMIZATION Survey on adherence to annual OGTT in thalassemia

  Vincenzo De Sanctis

  e2025008

  2024-12-31

  https://doi.org/10.4084/MJHID.2025.008

  2937

  PDF: 1353

  HTML: 161

• GLUCOSE HOMEOSTASIS AND ΑSSESSMENT OF Β-CELL FUNCTION BY 3-HOUR ORAL GLUCOSE TOLERANCE (OGTT) IN PATIENTS WITH Β-THALASSEMIA MAJOR WITH SERUM FERRITIN BELOW 1,000 NG/DL: RESULTS FROM A SINGLE ICET-A CENTRE OGTT in thalassemia and iron overload

  Vincenzo De Sanctis, Ashraf Soliman, Shahina Daar, Ploutarchos Tzoulis , Salvatore Di Maio, Christos Kattamis

  e2023006

  2023-01-01

  https://doi.org/10.4084/MJHID.2023.006

  3969

  PDF: 1125

  HTML: 460

• MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA

  Melanie Joannides, Ashley N Mays, Anita R Mistry, Syed Khizer Hasan, Andreas Reiter, Joseph L Wiemels, Carolyn A Felix, Francesco Lo-Coco, Neil Osheroff, Ellen Solomon, David Grimwade

  e2011045

  2011-10-24

  https://doi.org/10.4084/mjhid.2011.045

  2880

  PDF: 858

  HTML: 6533

  Untitled: 236

  Untitled: 200

  Untitled: 212

  Untitled: 225

• COEXISTENCE OF MULTIPLE GENE VARIANTS IN SOME PATIENTS WITH ERYTHROCYTOSES Multiple gene variants in erythrocytosis

  Andrea Benetti, Irene Bertozzi, PhD, MD, Giulio Ceolotto, Irene Cortella, Daniela Regazzo, Giacomo Biagetti, Elisabetta Cosi, Maria Luigia Randi, MD, Prof

  e2024021

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.021

  873

  PDF: 1247

  HTML: 137

• Bladder microbiota snapshots help to monitor urinary tract infections in vulnerable patients

  Giulia Santarelli, Delia Mercedes Bianco, Margherita Capriati, Maurizio Sanguinetti, Claudia Rendeli, Flavio De Maio

  e2025028

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.028

  806

  PDF: 661

  HTML: 111

• The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones

  Antonio Cristiano, Raffaele Palmieri, Emiliano Fabiani, Tiziana Ottone, Mariadomenica Divona, Arianna Savi, Francesco Buccisano, Luca Maurillo, Corrado Tarella, William Arcese, Maria Teresa Voso

  e2022041

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.041

  1277

  PDF: 772

  HTML: 320

• LIGHT CHAIN AMYLOIDOSIS

  Paolo Milani, Giampaolo Merlini, Giovanni Palladini

  e2018022

  2018-03-01

  https://doi.org/10.4084/mjhid.2018.022

  5873

  PDF: 2346

  HTML: 1337

• PREVALENCE AND AETIOLOGY OF BACTEREMIA IN FEBRILE CHILDREN WITH SICKLE CELL DISEASE AT A NIGERIA TERTIARY HOSPITAL

  Biobele Jotham Brown, Hannah O Dada-Adegbola, Catherine Trippe, Olufunmilayo Olopade

  e2017039

  2017-06-20

  https://doi.org/10.4084/mjhid.2017.039

  2985

  PDF: 1291

  HTML: 1016

• Fournier's Gangrene Complicating Hematologic Malignancies: Literature Review and Treatment Suggestions

  Giovanni D'Arena, Giuseppe Pietrantuono, Emilio Buccino, Giancarlo Pacifico, Pellegrino Musto

  e2013067

  2013-11-04

  https://doi.org/10.4084/mjhid.2013.067

  1594

  PDF: 863

  HTML: 187080

• INVASIVE CANDIDA INFECTIONS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES AND HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: CURRENT EPIDEMIOLOGY AND THERAPEUTIC OPTIONS.

  Corrado Girmenia, Erica Finolezzi, Vincenzo Federico

  e2011013

  2011-03-14

  https://doi.org/10.4084/mjhid.2011.013

  2293

  PDF: 979

  HTML: 1859

• MEGAKARYOCYTE CONTRIBUTION TO BONE MARROW FIBROSIS: MANY ARROWS IN THE QUIVER

  Alessandro Malara, Vittorio Abbonante, Maria Zingariello, Anna Rita Franco Migliaccio, Alessandra Balduini

  e2018068

  2018-11-01

  https://doi.org/10.4084/mjhid.2018.068

  2631

  PDF: 1685

  HTML: 653

• PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION

  Isidro Jarque, Miguel Salavert, Javier Pemán

  e2016035

  2016-07-01

  https://doi.org/10.4084/mjhid.2016.035

  3722

  PDF: 1245

  HTML: 3908

  Untitled: 229

  Untitled: 266

• THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA

  Xenofon Papanikolaou, Bart Barlogie, Saad Usmani

  e2011047

  2011-10-24

  https://doi.org/10.4084/mjhid.2011.047

  2491

  PDF: 796

  HTML: 1738

• THE ROLE OF WHITE BLOOD CELL COUNT IN PERIANAL PATHOLOGIES: A RETROSPECTIVE ANALYSIS OF HEMATOLOGIC MALIGNANCIES Role of white blood cell count in perianal pathologies

  Bedrettin Orhan, Fahir Özkalemkaş, Vildan Özkocaman, Büşra Gürbüz, Tuba Ersal, İbrahim Ethem Pınar, Cumali Yalçın, Ömer Candar, Sinem Çubukçu, Tuba Güllü Koca, Rıdvan Ali

  e2022051

  2022-06-29

  https://doi.org/10.4084/MJHID.2022.051

  3593

  PDF: 1930

  HTML: 245

• BACTERIAL EPIDEMIOLOGY AND ANTIMICROBIAL RESISTANCE IN THE SURGERY WARDS OF A LARGE TEACHING HOSPITAL IN SOUTHERN ITALY

  Silvano Esposito, Renato Gioia, Giuseppe De Simone, Silvana Noviello, Sebastiano Leone

  e2015040

  2015-05-26

  https://doi.org/10.4084/mjhid.2015.040

  2207

  PDF: 1289

  HTML: 1414

• Immune Biomarker Signature in the Diagnostic Workup of Fever Without Source: A Pilot Study

  Angela Maria Di Francesco, Giuliana Pasciuto, Laura Gerardino, Ludovico Luca Sicignano, Elena Verrecchia, Andrea Urbani, Donato Rigante, Raffaele Manna

  2026-02-28

  https://doi.org/10.4084/MJHID.2026.030

  489

  PDF: 387

  HTML: 149

• Prevention of Early Death in Very Elderly Acute Promyelocytic Leukemia Patients Using Lower Induction Doses of All-trans Retinoic Acid

  Mark Dalgetty, Sruthi Dontu, Chandini Kannan, Amany Keruakous, Locke Bryan, Vamsi Kota, Anand Jillella

  e2025066

  2025-08-31

  https://doi.org/10.4084/MJHID.2025.066

  929

  PDF: 638

  Html: 137

• I INCREASED RISK OF LYMPHOMA IN MEN INFECTED WITH TUBERCULOSIS

  guangliang Chen

  e2021053

  2021-08-28

  https://doi.org/10.4084/MJHID.2021.053

  1169

  PDF: 486

  HTML: 328

• COVID-19 induces prolonged immunological exhaustion leading to relapse of hematological malignancies except in hematopoietic cell transplant recipients

  SUPARNO CHAKRABARTI, Snigdha Banerjee, Mahak Agarwal, Gitali Bhagawati, Nilanjan Saha, SARITA JAISWAL

  e2025042

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.042

  1042

  PDF: 748

  HTML: 126

• CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA

  Michele Bibas, Jorge J Castillo

  e2014064

  2014-10-22

  https://doi.org/10.4084/mjhid.2014.064

  2638

  PDF: 1632

  HTML: 2373

  Table1: 195

• Successful Treatment with Imipenem/Cilastatin/Relebactam of a Polymicrobial Bacteremia due to Meropenem/Vaborbactam-Resistant KPC-Producing Klebsiella pneumoniae and Enterococcus faecalis

  Federico Marzi, Mario Alessandri, Veronica De Crescenzo, Stefania Del Vecchio, Simone Radi, Maurizio Manini

  e2026037

  2026-04-30

  https://doi.org/10.4084/MJHID.2026.037

  254

  HTML: 92

  PDF: 114

• FEVER OF UNKNOWN ORIGIN AND MULTIDRUG-RESISTANT ORGANISMS COLONIZATION IN AML PATIENTS.

  Luca Guarnera, Gentiana Elena Trotta, Valentina Boldrini, Lucia Cardillo, Ilaria Cerroni, Valeria Mezzanotte, Gianmario Pasqualone, Arianna Savi, Beatrice Borsellino, Elisa Buzzatti, Raffaele Palmieri, Giovangiacinto Paterno, Luca Maurillo, Francesco Buccisano, Adriano Venditti, Maria Ilaria Del Principe

  e2023013

  2023-01-01

  https://doi.org/10.4084/MJHID.2023.013

  2137

  PDF: 1165

  HTML: 470

• ACQUIRED REFRACTORY IRON DEFICIENCY

  Margherita Migone De Amicis, Alessandro Rimondi, Luca Elli, Irene Motta

  e2021028

  2021-04-29

  https://doi.org/10.4084/MJHID.2021.028

  3409

  PDF: 1151

  HTML: 1092

• Sickle Cell Disease: Management options and challenges in developing countries

  Daniel Ansong, Alex Osei-Akoto, Delaena Ocloo, Kwaku Ohene-Frempong Ohene-Frempong

  e2013062

  2013-11-04

  https://doi.org/10.4084/mjhid.2013.062

  2551

  PDF: 1300

  HTML: 1026

• POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.

  Sinem Başak Tan Öksüz, Güldane Cengiz Seval, Klara Dalva, Selami Koçak Toprak

  2026-02-28

  https://doi.org/10.4084/MJHID.2026.028

  1039

  PDF: 491

  Suppl. Files: 125

  HTML: 124

• Routine inflammatory markers are elevated in myelodysplastic syndromes at presentation Inflammatory marker elevation in MDS

  Howard Oster, Ekaterina Sklyar, Noa Golsdshmidt, Moshe Mittelman

  e2023044

  2023-06-29

  https://doi.org/10.4084/MJHID.2023.044

  895

  PDF: 669

  HTML: 229

• The possible role of chronic infection in the etiopathogenesis of a case of 5q-syndrome associated with tuberculosis and abnormality of the X chromosome.

  Lubomir Mitev

  e2022079

  2022-10-29

  https://doi.org/10.4084/MJHID.2022.079

  1437

  PDF: 491

  HTML: 271

• MOLECULAR HETEROGENEITY IN ACUTE PROMYELOCYTIC LEUKEMIA - A SINGLE CENTRE EXPERIENCE FROM INDIA

  Nikhil Rabade, Goutham Raval, Shruti Chaudhary, PG Subramanian, Rohan Kodgule, Swapnali Joshi, Prashant Tembhare, Hasmukh Jain, Manju Sengar, Syed Hasan K, Pratibha Amare Kadam, Dhanalaxmi Shetty, Gaurav Narula, Shripad Banavali, Sumeet Gujral, Nikhil Patkar

  e2018002

  2018-01-01

  https://doi.org/10.4084/mjhid.2018.002

  3670

  PDF: 1210

  HTML: 1105

• Multiple bone and joint disease in a sickle cell anaemia patient: a case report

  John Ayodele Olaniyi, Adekunle E Alagbe, Olutoogun O Toluwalase, Olorunsogo E Busari

  e2012023

  2012-05-03

  https://doi.org/10.4084/mjhid.2012.023

  1284

  PDF: 747

  HTML: 1735

• A A RETROSPECTIVE LONG-TERM STUDY ON AGE AT MENARCHE AND MENSTRUAL CHARACTERISTICS IN 85 YOUNG WOMEN WITH TRANSFUSION-DEPENDENT Β-THALASSEMIA (TDT) BORN BETWEEN 1965 AND 1995 Long-Term Study on Age at Menarche and Menstrual Characteristics in patients with TDT

  Vincenzo De Sanctis, Salvatore Di Maio

  e2021040

  2021-06-28

  https://doi.org/10.4084/MJHID.2021.040

  1544

  PDF: 508

  HTML: 181

• Sickle cell disease and Bartonella spp. infection

  Paulo Eduardo Neves Ferreira Velho, Marna Elise Ericson, David Mair, Kalpna Gupta

  e2012046

  2012-06-30

  https://doi.org/10.4084/mjhid.2012.046

  1212

  PDF: 882

  HTML: 458

• Impact of the Addition of Daratumumab to the Standard Bortezomib-Thalidomide-Dexamethasone Regimen on Hematopoietic Stem Cell Mobilization and Collection, Post-Transplant Engraftment and Infectious Complications: A Case-Control Multicentre Real-Life Analy

  Gianluca Cavallaro

  e2024049

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.049

  2235

  HTML: 144

  PDF: 1134

• How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency

  Marco Sanna, Giovanni Caocci, Giorgio La Nasa

  e2017047

  2017-08-14

  https://doi.org/10.4084/mjhid.2017.047

  1845

  PDF: 922

  HTML: 970

  Referring article: 754

• PERCEPTION OF COMMUNITY HEALTH CARE WORKERS ABOUT PATIENTS WITH SICKLE CELL DISEASE IN PRIMARY HEALTH CARE AFTER AN EDUCATIONAL INTERVENTION

  Ludmila Mourão Xavier Gomes, Marcos Borato Viana, Igor Alcântara Pereira

  22015031

  2015-04-19

  https://doi.org/10.4084/mjhid.2015.031

  2115

  PDF: 975

  HTML: 1661

• Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.

  Abraham Tareq Yacoub, Mitsuya Katayama, JoAnn Tran, Ronit Zadikany, Manasa Kandula, John Norman Greene

  e2014031

  2014-04-06

  https://doi.org/10.4084/mjhid.2014.031

  2503

  PDF: 1322

  HTML: 1791

  CoverLetter: 185

• “Hemolysis, or not Hemolysis, that is the question”. Use of hydroxychloroquine in a patient with COVID-19 infection and G6PD deficiency. Hemolysis by Hemolysis and G6PD deficiency.

  NICOLA SGHERZA, Lidia Dalfino, Antonio Palma, Angelantonio Vitucci, Daniela Campanale, Salvatore Grasso, Pellegrino Musto

  e2020076

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.076

  1392

  PDF: 1001

  HTML: 353

• DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY

  John Norman Greene, Abraham Tareq Yacoub, Dani Thomas, Carol Yuan, Frank Walsh, David Solomon, Skai Schwartz, Arthur Andrews

  e2015002

  2014-12-19

  https://doi.org/10.4084/mjhid.2015.002

  1984

  PDF: 827

  HTML: 2206

  Table 1: 183

  Table 2: 204

  Table 3: 197

  Table 4: 203

  Table 5: 198

  Tble 6: 191

  Cover Letter: 211

  Greene Tab.7: 200

• TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH HIGH WHITE CELL BLOOD COUNTS.

  Charicleia Kelaidi, Lionel Ades, Pierre Fenaux

  e2011038

  2011-09-08

  https://doi.org/10.4084/mjhid.2011.038

  2511

  PDF: 954

  HTML: 2372

• Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis

  Marianna Criscuolo, Luana Fianchi, Patrizia Chiusolo, Simona Sica, Livio Pagano

  e2026060

  2026-06-30

  https://doi.org/10.4084/MJHID.2026.060

  1983

  PDF: 72

  HTML: 21

• SUBTYPE DISTRIBUTION AND MUTATION SPECTRUM THALASSEMIA IN CHILDREN UNDER 10 YEARS IN NORTHERN VIETNAM

  Ngoc Dung Nguyen, Ha Thanh Nguyen, Thi Chi Nguyen, Thi Nguyet Anh Phi, Thi Thu Ha Nguyen, Thi Thu Huyen Le, Phuong Linh Hoang, Duc Binh Vu

  e2026002

  2026-01-01

  https://doi.org/10.4084/MJHID.2026.002

  971

  PDF: 660

  Html: 187

• Guest Editor: Pellegrino Musto HOW FIRST-LINE THERAPY IS CHANGING IN NON-TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS.

  Daniele Derudas

  e2025025

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.025

  1569

  PDF: 1386

  HTML: 116

• Acquired von Willebrand Syndrome associated to secondary IgM MGUS emerging after Autologous Stem Cell Transplantation for AL Amyloidosis

  Victor H Jimenez-Zepeda, Hina Qamar, Adrienne Lee, Karen Valentine, Leslie Skeith

  e2017034

  2017-05-01

  https://doi.org/10.4084/mjhid.2017.034

  2662

  PDF: 1049

  HTML: 1175

• Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy

  Pasquale Niscola

  e2013030

  2013-04-16

  https://doi.org/10.4084/mjhid.2013.030

  1199

  PDF: 768

  HTML: 1373

  Figure 1: 195

  Figure 2: 197

• PREVENTION AND TREATMENT OF HEPATITIS VIRUS INFECTION IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS

  Suparno Chakrabarti, Somnath Mukherjee

  e2009017

  2009-12-10

  https://doi.org/10.4084/mjhid.2009.017

  842

  PDF: 562

  HTML: 2461